I want to agree with you. I really do. But somehow
Post# of 148282
They knew leronlimab was safe and effective for HIV a couple years ago. And yet here we are, still the bridesmaid.
I understand the general philosophy that if the FDA moves the yardstick for one company during the approval process, it becomes a slippery slope. Other drugs, however, don't typically have a 1,000+ patient pool demonstrating safety and efficiency.
I am cautiously optimistic. I wonder if we'll at least get a bump in the interim period between announcement of the topline results and the FDA ruling.